Two New Ebola Vaccine Candidates Added to Trial in DRC
Audio narration · Coming soon
The World Health Organization expert groups have recommended including two new Ebola vaccine candidates in the ongoing Tumaini clinical trial in the Democratic Republic of the Congo. This marks the first evaluation of vaccines specifically targeting the Bundibugyo virus during an active outbreak. The decision aims to advance treatment research for the current Ebola outbreak.
Why this matters
PRISM scored this story 65/100 for interest.
Originally published by gnews